Introduction {#s01}
============

A hallmark of cell polarity in many migratory cell types is the orientation of the centrosome to a position between the nucleus and leading edge ([@bib33]; [@bib20]). The inability of cells to establish and maintain anterior centrosome orientation results in inefficient migration. Direct imaging of the centrosome in fibroblasts demonstrates that productive protrusion and migration occur only after anterior centrosome orientation is achieved ([@bib14]). In wounded monolayers of fibroblasts and myoblasts polarizing for migration, anterior centrosome orientation is established by the coordinated positioning of the nucleus and centrosome. During this process, retrograde actin flow moves the nucleus toward the cell rear, whereas the centrosome is maintained at the cell center ([@bib14]; [@bib7]). In fibroblasts, the maintenance of the centrosome at the cell center depends on the polarity proteins Par3, Par6, and PKCζ, the minus end--directed microtubule (MT) motor protein dynein, and dynamic MTs ([@bib46]; [@bib14]; [@bib52]).

In fibroblasts and myoblasts, forces generated by the retrograde flow of dorsal perinuclear actin cables are harnessed by the nucleus through transmembrane actin-associated nuclear (TAN) lines ([@bib35]; [@bib7]). TAN lines are composed of the outer nuclear membrane (ONM) and inner nuclear membrane (INM) proteins nesprin-2G (N2G) and SUN2, respectively. N2G is an ∼800-kD spectrin repeat--containing protein, the majority of which extends into the cytosol ([@bib34]). N2G interacts with dorsal perinuclear actin cables through its N-terminal actin-binding calponin homology domains, resulting in the organization of N2G into TAN lines ([@bib71]; [@bib35]). The C terminus of N2G contains the conserved KASH (*Klarsicht*, *ANC-1*, and *Syne* homology) domain, which consists of a transmembrane domain (TMD) followed by an ∼20--30-aa KASH peptide that directly interacts with the conserved *Sad1*/*UNC-84* (SUN) domain found at the C terminus of SUN2 ([@bib44]; [@bib58]). The N terminus of SUN2 projects into the nucleoplasm and interacts with the nuclear lamina as well as the chromatin ([@bib9]; [@bib58]; [@bib62]). The anchorage of TAN lines by A-type lamins is essential for rearward nuclear movement ([@bib11]; [@bib7]). The fundamental significance of rearward nuclear movement during cell migration is illustrated by the fact that both N2G and SUN2 are required for efficient fibroblast migration ([@bib35]). Furthermore, N2G depletion inhibits myoblast migration and decreases the efficiency of their fusion into myotubes ([@bib7]). Despite their importance, the mechanisms of TAN line assembly remain poorly defined.

The KASH--SUN interaction forms an evolutionarily conserved molecular bridge across the perinuclear space, termed the linker of nucleoskeleton and cytoskeleton (LINC) complex ([@bib62]; [@bib8]). The crystal structure of SUN2 reveals a mushroom-like trimer with a cap composed of SUN domains and a stalk of three coiled-coils ([@bib57], [@bib58]; [@bib72]). Each SUN2 trimer binds three KASH peptides in grooves that are formed between adjacent SUN domains. LINC complexes are typically depicted as being evenly distributed throughout the nuclear envelope ([@bib60]). However, the identification of TAN lines argues that LINC complexes are dynamic within nuclear membranes. This idea is further supported by the observed reorganization of LINC complexes into focal accumulations during meiosis in *Caenorhabditis elegans* and during nuclear centering in the fission yeast *Schizosaccharomyces pombe* ([@bib30]; [@bib50]). Therefore, a molecular mechanism for the regulation of LINC complex dynamics within the nuclear envelope must exist, although currently it is unknown.

Several lines of evidence implicate the conserved ATP-binding protein torsinA (TA) as a key regulator of LINC complex dynamics ([@bib12]; [@bib1]; [@bib51]). TA was originally identified as the protein product encoded by the *TOR1A* gene, which causes the childhood movement disorder DYT1 dystonia when mutated ([@bib45]). The mutation is an in-frame deletion that removes a single glutamic acid (ΔE302/303, or ΔE) that impairs TA function in part by impairing the interaction of TA with its major interacting proteins, LAP1 and luminal domain (LD)--like LAP1 (LULL1; [@bib16]; [@bib40]; [@bib69]). Although LAP1 is an INM protein ([@bib54]), LULL1 is distributed throughout the ER and, consequently, the ONM ([@bib67]; [@bib17], [@bib18]).

TA is a member of the AAA+ (ATPase associated with various cellular activities) superfamily, members of which typically function as ring-shaped hexameric molecular chaperones that use energy derived from ATP hydrolysis to remodel protein complexes ([@bib45]; [@bib63]; [@bib22]). Studies of TA exhibiting chaperone-like behaviors both in vitro and in vivo are consistent with the hypothesis that, like AAA+ proteins, TA may act as a molecular chaperone ([@bib4]; [@bib42]).

Torsin proteins themselves have negligible ATPase activity in vitro ([@bib69]). However, their activity is stimulated by a direct interaction with the ∼60% identical LD of LAP1 (LAP1^LD^) or LULL1 (LULL1^LD^; [@bib16]; [@bib69]; [@bib3]; [@bib59]). The LAP1^LD^ possesses an atypical AAA+ fold in which R442 is positioned similarly to the arginine finger of canonical AAA+ proteins ([@bib3]; [@bib59]). Arginine fingers are structural features of AAA+ proteins thought to coordinate nucleotide hydrolysis ([@bib22]). Because TA lacks identifiable arginine fingers, the TA--LAP1 interaction was postulated to result in the formation of an alternating (LAP1-TA)~3~ heterohexamer, through which the R442 of LAP1 could coordinate ATP hydrolysis with an adjacent TA ([@bib3]; [@bib59]). This proposed mechanism is supported by the reduced ability of LAP1^LD^ constructs lacking the proposed arginine finger to stimulate the ATPase activity of TA in vitro ([@bib3]; [@bib59]).

Moreover, TA and the four additional mammalian torsin proteins (torsinB \[TB\], torsin2A \[T2\], torsin3A \[T3\], and torsin4A \[T4\]) are the only AAA+ proteins known to reside within the ER lumen and contiguous perinuclear space ([@bib15]; [@bib39]; [@bib27]; [@bib29]). Although the functional relevance is unclear, TA is known to interact with TB ([@bib24]). Among the torsins, T4 is unique because of the presence of a predicted TMD ([@bib48]). Despite these important advances in our understanding of the biochemical mechanism of torsin activity, the protein substrates remodeled by the torsins within the shared ER/perinuclear space remain unknown.

Experimental data suggest that TA has affinity for the KASH domains from nesprin-1, -2, and -3 ([@bib41]), hinting that it might remodel LINC complexes within the nuclear envelope. Studies of the effects of TA inhibition on the architecture of the nuclear envelope provide indirect evidence of TA-mediated LINC complex regulation ([@bib39]; [@bib17]), as both TA and LINC complexes have been implicated in the maintenance of the typical 30--50-nm distance between the INM and ONM ([@bib39]; [@bib9]; [@bib5]). Furthermore, cells lacking TA redistribute nesprin-3α from the nuclear envelope to the ER, whereas cells with elevated levels of TA exhibit disrupted nuclear envelope localization of N2G, nesprin-3, and SUN2 ([@bib41]; [@bib64]). Finally, the *C. elegans* TA homologue OOC-5 is required for the proper localization of the nesprin homologue ZYG-12 in the nuclear envelope of germ cell nuclei ([@bib66]). Collectively, these data suggest that TA regulates the LINC complex from within the nuclear envelope.

Although TA has been implicated in centrosome orientation in migrating fibroblasts ([@bib42], [@bib43]), the mechanism responsible for its role in this process is unclear, as neither centrosomes nor nuclear positioning were analyzed in these studies. Furthermore, the participation of the other torsin proteins, as well as LAP1 and LULL1, in centrosome orientation is unexplored. Therefore, we sought to elucidate the mechanism of TA-mediated centrosome orientation in migrating fibroblasts, hypothesizing that TA is either required for rearward nuclear movement or for centrosome centration during centrosome orientation.

Results {#s02}
=======

TA is required for rearward nuclear movement during centrosome orientation {#s03}
--------------------------------------------------------------------------

To begin to determine the mechanism of TA-dependent centrosome orientation, we first asked whether acute siRNA-mediated depletion of TA inhibited lysophosphatidic acid (LPA)--stimulated centrosome orientation in serum-starved wound-edge NIH3T3 fibroblasts ([@bib46]; [@bib35]). We tested the ability of four independent siRNAs to efficiently knock down TA mRNA and protein levels relative to control cells treated with previously characterized GAPDH and noncoding (NC) siRNAs ([@bib35]; [@bib31]). All four TA-targeting siRNAs significantly depleted TA protein levels (Fig. S1 A). Each of the TA-targeting siRNAs significantly inhibited centrosome orientation and rearward nuclear positioning in NIH3T3 fibroblasts relative to controls without rearward displacement of the centrosome ([Fig. 1, B--D](#fig1){ref-type="fig"}; and Fig. S1, B and C). Importantly, the expression of a previously described construct encoding wild-type (WT) TA with EGFP inserted after its signal sequence (SS; SS-EGFP-TA^WT^; [@bib15]) rescued the centrosome orientation and rearward nuclear positioning defects observed in cells treated with siRNA TA.1, indicating that these defects were specifically caused by TA depletion ([Fig. 1, A--D](#fig1){ref-type="fig"}). For the remainder of this work, we used siRNA TA.1 to deplete TA. Similar results were obtained after LPA stimulation of serum-starved mouse embryonic fibroblasts (MEFs) from *Tor1A^−/−^* mice ([Fig. 1, B--D](#fig1){ref-type="fig"}; and Fig. S1 D; [@bib17]). Again, both centrosome orientation and rearward nuclear positioning in *Tor1A^−/−^* MEFs were rescued by SS-EGFP-TA^WT^ expression ([Fig. 1, B--D](#fig1){ref-type="fig"}).

![**TA depletion inhibits rearward nuclear movement during centrosome orientation.** (A) Diagrams of the human TA protein and SS-EGFP-TA^WT^. Protein domains were identified using the SMART platform ([@bib53]). NTD, N-terminal domain ([@bib65]). (B) Representative epifluorescence images of centrosome orientation in NIH3T3 fibroblasts treated with GAPDH or TA.1 siRNA as well as *Tor1A^+/+^* and *Tor1A^−/−^* MEFs. TA-depleted NIH3T3 fibroblasts and *Tor1A^−/−^* MEFs expressing SS-EGFP-TA^WT^ are also shown (arrowheads and insets). Asterisks indicate oriented centrosomes. (C) Centrosome orientation in the cells described in B. The dashed yellow line denotes random orientation, which is ∼33% ([@bib46]). (D) Mean centrosome and nucleus positions from the cells described in B. The cell center is defined as 0. Positive values are toward the leading edge, and negative values are away. *n* ≥ 251. (E) Representative montages of DIC images of nuclear movement during centrosome orientation in wound-edge NIH3T3 fibroblasts treated with NC or TA.1 siRNA as well as *Tor1A^+/+^* and *Tor1A^−/−^* MEFs. A DIC montage of wound-edge cells expressing SS-EGFP-TA^WT^ (insets) is also provided. Nuclei are outlined by dashed white lines. Time is relative to the addition of LPA (0 min). (F) Percentages of the cells described in E with rearward moving nuclei. (G) Mean velocities of nuclear movement from cells described in E. *n* ≥ 14. Bars, 10 µm. Error bars show SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001; ns, not significant.](JCB_201507113_Fig1){#fig1}

To determine whether the nuclear positioning defect was caused by a lack of rearward nuclear movement, we performed live-cell differential interference contrast (DIC) imaging in LPA-stimulated wound-edge TA-depleted and control NIH3T3 fibroblasts. We found that the percentage of cells with rearward-moving nuclei and the speed of rearward nuclear movement were both significantly reduced in cells depleted of TA relative to controls ([Fig. 1, E--G](#fig1){ref-type="fig"}). Importantly, the expression of SS-EGFP-TA^WT^ in the TA-depleted cells restored both of these defects to control levels. Also consistent with TA-depleted NIH3T3 fibroblasts, live-cell DIC imaging of *Tor1A^−/−^* MEFs confirmed that TA was required for proper rearward nuclear movement because both the percentage of cells with rearward-moving nuclei and the speed of nuclear movement were impaired in *Tor1A^−/−^* MEFs relative to *Tor1A^+/+^* MEFs ([Fig. 1, E--G](#fig1){ref-type="fig"}). Moreover, both of these defects could be rescued by SS-EGFP-TA^WT^ expression. Collectively, these results demonstrate that TA functions during centrosome orientation to promote rearward nuclear movement.

The redox-regulated ATPase activity of TA is required for rearward nuclear movement during centrosome orientation {#s04}
-----------------------------------------------------------------------------------------------------------------

To address the molecular mechanism responsible for TA-dependent rearward nuclear movement and centrosome orientation, we expressed a TA construct encoding a mutation in the conserved Walker B motif (SS-EGFP-TA^E171Q^; [Fig. 2 A](#fig2){ref-type="fig"}; [@bib16]) in wound-edge NIH3T3 fibroblasts, which were then stimulated with LPA. TA^E171Q^ does not hydrolyze ATP in the presence of the LD of LAP1 or LULL1 ([@bib69]), and similar ATP hydrolysis--impaired Walker B mutations are often used as dominant-negative constructs to disrupt AAA+ protein function ([@bib22]). Unlike cells expressing SS-EGFP-TA^WT^, those expressing SS-EGFP-TA^E171Q^ were significantly reduced in their ability to orient their centrosomes and in rearward nuclear positioning ([Fig. 2, B--D](#fig2){ref-type="fig"}). Knowing that SS-EGFP-TA^E171Q^ acts in a dominant-negative fashion to inhibit centrosome orientation, we next asked whether a similar approach could be used to test whether TB, T2, and T3 also functioned during this process. However, expression of SS-EGFP--tagged WT or Walker B mutant constructs of TB, T2, and T3 had no effect on centrosome orientation or rearward nuclear positioning in LPA-stimulated wound-edge cells (Fig. S2). These results further support the requirement for TA-mediated rearward nuclear positioning during centrosome orientation in migrating fibroblasts, and they suggest that the three other luminal torsins are not critically involved in this process.

![**The redox-regulated ATPase activity of TA is required for rearward nuclear positioning and centrosome orientation.** (A) Diagram indicating the location of the designated mutations in the TA constructs used in this figure. (B) Representative epifluorescence images of centrosome orientation in wound-edge NIH3T3 fibroblasts expressing the indicated construct (arrowheads and insets). (C) Centrosome orientation in the cells described in B. (D) Mean centrosome and nucleus positions in the cells described in B. *n* ≥ 69. (E) Representative epifluorescence images of centrosome orientation in *Tor1A^−/−^* MEFs expressing the indicated SS-EGFP-TA^X^ constructs (arrowheads and inserts). Asterisks indicate oriented centrosomes. (F) Centrosome orientation in the cells described in E. (C and F) Dashed yellow lines denote random centrosome orientation. (G) Mean centrosome and nucleus positions in the cells described in E. *n* ≥ 115. Bars, 10 µm. Error bars show SEM. \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001; ns, not significant.](JCB_201507113_Fig2){#fig2}

To further test the requirement for the ATPase activity of TA during centrosome orientation, we asked whether expressing SS-EGFP-TA^E171Q^ or SS-EGFP-TA^K108A^, a construct encoding a mutation within the AAA+ Walker A domain predicted to prevent ATP binding ([@bib15]; [@bib22]), could rescue centrosome orientation and rearward nuclear positioning in *Tor1A^−/−^* MEFs ([Fig. 2, A and E--G](#fig2){ref-type="fig"}). Neither of these constructs nor SS-EGFP-TA^ΔE^, which encodes the ATPase-defective DYT1 dystonia-causing ΔE mutation ([@bib69]), were able to rescue the centrosome orientation and nuclear positioning defects observed in the *Tor1A^−/−^* MEFs ([Fig. 2, A and E--G](#fig2){ref-type="fig"}). Next, we tested the requirement for the C-terminal redox-sensitive sensor II motif (RSS), which is composed of two conserved disulfide bond--forming cysteine residues, C280 and C319, and is required for the nucleotide- and partner-binding functions of TA ([@bib73], [@bib74]). We mutated each cysteine in the RSS to serine in SS-EGFP-TA either independently (SS-EGFP-TA^C280S^ and SS-EGFP-TA^C319S^) or together (SS-EGFP-TA^C280,319S^) and expressed the resulting constructs in *Tor1A^−/−^* MEFs ([Fig. 3, A and E--G](#fig3){ref-type="fig"}). None of the cysteine mutants rescued centrosome orientation or rearward nuclear positioning ([Fig. 3, A and E--G](#fig3){ref-type="fig"}). These results demonstrate that the redox-regulated ATPase activity of TA is required for rearward nuclear positioning during centrosome orientation in wound-edge fibroblasts.

![**LAP1 is required for rearward nuclear movement during centrosome orientation.** (A) Representative epifluorescence images of centrosome orientation in NIH3T3 fibroblasts treated with siRNA. A LAP1-depleted cell expressing EGFP-LAP1^WT^ is shown (arrowhead and inset). (B) Centrosome orientation in the cells described in A. (C) Mean centrosome and nucleus positions in the cells described in B. *n* ≥ 139. (D) Representative montages of DIC images of nuclear movement during centrosome orientation in NIH3T3 fibroblasts treated with NC or LAP1.1 siRNA. A DIC montage of LAP1-depleted cells expressing EGFP-LAP1^WT^ (inset) is provided. Nuclei are outlined by dashed white lines. (E) Percentages of the cells described in D with rearward-moving nuclei. (F) Mean velocities of nuclear movement from cells described in D. (G) Representative epifluorescence images of centrosome orientation in LAP1-depleted NIH3T3 fibroblasts expressing the indicated EGFP-LAP1^X^ construct (arrowheads and insets). Asterisks indicate oriented centrosomes. (H) Centrosome orientation in the cells described in G. (B and H) Dashed yellow lines denote random centrosome orientation. (I) Mean centrosome and nucleus positions in the cells described in G. *n* ≥ 11. Bars, 10 µm. Error bars show SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; ns, not significant.](JCB_201507113_Fig3){#fig3}

LAP1 is required for rearward nuclear movement during centrosome orientation {#s05}
----------------------------------------------------------------------------

To determine whether LAP1 or LULL1 contributed to rearward nuclear movement during centrosome orientation, we depleted each protein from NIH3T3 fibroblasts with siRNA (Fig. S3, A--C). LAP1 depletion negatively impacted both centrosome orientation and rearward nuclear positioning in cells after LPA stimulation, whereas no significant effect was observed with LULL1 depletion ([Fig. 3, A--C](#fig3){ref-type="fig"}). We obtained similar results with independent siRNAs directed against LAP1 and LULL1 (Fig. S3, A--E). Expression of EGFP-tagged LAP1 (EGFP-LAP1^WT^) in LAP1-depleted cells rescued centrosome orientation and rearward nuclear positioning ([Fig. 3, A--C](#fig3){ref-type="fig"}). Live-cell DIC imaging revealed that the percentage of LAP1-depleted cells that displayed rearward nuclear movement and the speed of rearward nuclear movement were both significantly reduced relative to controls ([Fig. 3, D--F](#fig3){ref-type="fig"}). Both of these parameters were rescued by EGFP-LAP1^WT^ expression in the LAP1-depleted cells ([Fig. 3, D--F](#fig3){ref-type="fig"}). Thus, these results indicate that LAP1, like TA, is required for rearward nuclear movement during centrosome orientation and suggest that LULL1 is largely dispensable for this process.

To begin to explicate the mechanism of LAP1 function during centrosome orientation, we tested the ability of various EGFP-tagged LAP1 constructs to rescue rearward nuclear positioning during centrosome orientation in LAP1-depleted NIH3T3 fibroblasts (Fig. S3 F). Neither the nucleoplasmic domain (ND; EGFP-LAP1^ND^) nor the LD plus TM domain (EGFP-LAP1^LD^) of LAP1 rescued centrosome orientation ([Fig. 3, G--I](#fig3){ref-type="fig"}). However, EGFP-LAP1^LD^ expression partially rescued rearward nuclear positioning in LAP1-depeleted cells ([Fig. 3, G--I](#fig3){ref-type="fig"}). To further explore this result and to test the role of LAP1-mediated stimulation of the ATPase activity of TA during this process, we attempted to rescue LAP1-depleted cells by expressing a LAP1 construct lacking the conserved arginine critical for stimulating the ATPase activity of TA (EGFP-LAP1^R442A^; [Fig 3, G--I](#fig3){ref-type="fig"}; and Fig S3 F; [@bib3]; [@bib59]). Because EGFP-LAP1^R442A^ expression rescued both centrosome orientation and rearward nuclear positioning in LAP1-depleted cells ([Fig. 3, G--I](#fig3){ref-type="fig"}), these results suggest that LAP1 promotes rearward nuclear positioning during centrosome orientation in a manner that is independent of its ability to stimulate the ATPase activity of TA.

As a final test of the differential requirement for LAP1 and LULL1 during centrosome orientation and rearward nuclear positioning, we fused the LULL1^LD^ to the LAP1^ND-TMD^ (EGFP-LAP1^ND-TMD^-LULL1^LD^) and attached the LAP1^LD^ to the cytoplasmic domain (CD) of LULL1 (EGFP-LULL1^CD-TMD^-LAP^LD^; Fig. S3 F). Similar constructs were previously used to show that the LAP1 ND and LULL1 CD mediate the subcellular localization of LAP1 to the INM and LULL1 to the ONM/ER, respectively ([@bib40]). Neither chimera rescued centrosome orientation or rearward nuclear positioning in the LAP1-depleted cells ([Fig. 3, G--I](#fig3){ref-type="fig"}). Thus, these results show that despite being ∼60% identical ([@bib16]), the LAP1^LD^ and LULL1^LD^ are not functionally equivalent. Moreover, these results suggest that the LAP1^LD^ needs to be localized at the INM to function during centrosome orientation.

TA and LAP1 are required for TAN line assembly and persistence {#s06}
--------------------------------------------------------------

Rearward nuclear movement requires N2G and SUN2 assembly into TAN lines, so we first tested whether TA or LAP1 depletion affected the nuclear envelope localization and/or total protein levels of N2G and SUN2. Quantitative immunofluorescence microscopy revealed that the steady-state levels of the TAN line proteins N2G or other nuclear envelope proteins (lamin A/C, nesprin-3, SUN1) were unchanged in the nuclear envelope of TA- or LAP1-depleted NIH3T3 fibroblasts stimulated with LPA (Fig. S4, A--D). However, a significant increase in the level of SUN2 in the nuclear envelope was observed in LAP1-depleted cells compared with controls (Fig. S4, C and D). In addition, we measured a significant reduction in the nuclear envelope levels of SUN1 and N2G in *Tor1A^−/−^* relative to *Tor1A^+/+^* MEFs (Fig. S4, E and F). In contrast, no significant differences were observed in the total protein levels of N2G, nesprin-3, SUN1, and SUN2 in NC-, GAPDH-, TA-, or LAP1-depleted cells (Fig. S4, G--J). Similar results were obtained in *Tor1A^+/+^* versus *Tor1A^−/−^* MEFs, though there was a significant decrease in N2G and SUN1 as well as a slight increase in SUN2 levels in the absence of TA (Fig. S4, K and L). Collectively, these results indicate that the role of TA and LAP1 during rearward nuclear movement might be separate from its role in regulating the levels or localization of LINC complex components.

We next examined the effect of TA and LAP1 depletion on the ability of wound-edge NIH3T3 fibroblasts to assemble TAN lines. We expressed the TAN line marker, EGFP--mini-N2G in TA-depleted or control cells stimulated with LPA. Linear arrays of EGFP--mini-N2G were considered TAN lines if they colocalized with dorsal perinuclear actin cables ([Fig. 4 A](#fig4){ref-type="fig"}; [@bib35]). Significantly fewer TA- and LAP1-depleted cells exhibited TAN lines as compared with control cells ([Fig. 4, A and B](#fig4){ref-type="fig"}). The number of TAN lines observed per cell was also reduced when either TA or LAP1 was depleted ([Fig. 4 C](#fig4){ref-type="fig"}). In addition, live-cell imaging revealed that the persistence of the TAN lines was significantly reduced in TA- and LAP1-depleted cells relative to controls ([Fig. 4, D and E](#fig4){ref-type="fig"}). This impaired persistence was not caused by the inability of SUN2 to properly localize to linear arrays of mini-N2G in the absence of TA function because the percentage of TAN lines containing endogenous SUN2 was unaffected by TA depletion or the expression of SS-EGFP-TA^E171Q^ (Fig. S5). Thus, these results demonstrate that both TA and LAP1 are required for the assembly of stable TAN lines.

![**The assembly of stable TAN lines requires both TA and LAP1.** (A) Representative epifluorescence images of nuclei in wound-edge NIH3T3 fibroblasts treated with siRNA and expressing EGFP--mini-N2G taken 1 h after LPA stimulation. Cells were stained for F-actin (red) and EGFP (green). (B) The mean number of cells with TAN lines quantified from the cells described in A. *n* ≥ 150. (C) The mean number of TAN lines per nucleus quantified from the cells described in A. (D) Representative kymographs of EGFP--mini-N2G fluorescence in wound-edge NIH3T3 fibroblasts treated with siRNA. Each panel is 0.2 µm. Arrowheads indicate TAN lines. Time after LPA addition is in minutes. (E) The mean TAN line persistence quantified from the experiments described in D. *n* ≥ 13. (F) Representative epifluorescence images of mCherry--mini-N2G TAN lines in NIH3T3 fibroblasts also expressing the indicated SS-EGFP-TA^X^ construct. White boxes indicate the area used for quantifying TAN line localization in G. (A and F) Arrowheads indicate TAN lines. Bars, 5 µm. (G) Quantification of SS-EGFP-TA^X^ recruitment to TAN lines. Error bars show SEM. \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001; ns, not significant. A.U., arbitrary units.](JCB_201507113_Fig4){#fig4}

To determine whether TAN lines themselves may be sites of TA function, we asked whether SS-EGFP-TA^E171Q^ preferentially localized to TAN lines in comparison with SS-EGFP-TA^WT^ because similar ATP hydrolysis--defective Walker B motif mutations are often used to trap the interaction between AAA+ proteins and their substrates ([@bib22]). Quantification of the localization of either construct to mCherry--mini-N2G TAN lines in serum-starved wound-edge cells stimulated with LPA demonstrated a significant enrichment of TA^WT^ and TA^E171Q^ on TAN lines relative to an adjacent TAN line--free area on the nuclear envelope ([Fig. 4, F and G](#fig4){ref-type="fig"}). In addition, we found that the presence of SS-EGFP-TA^E171Q^ resulted in a significant reduction in the amount of mCherry--mini-N2G signal measured in TAN lines as compared with TAN lines with SS-EGFP-TA^WT^ ([Fig. 4 G](#fig4){ref-type="fig"}). These results imply that TAN lines may contain substrates of TA, the remodeling of which is necessary for TAN line assembly and persistence.

TA is required for the dynamics of N2G and SUN2 within the nuclear envelope {#s07}
---------------------------------------------------------------------------

To assess how TA might contribute to TAN line assembly and persistence, we performed FRAP to measure the mobility and dynamics of previously described constructs encoding the EGFP-tagged LINC complex components mini-N2G, nesprin-3α, nesprin-3β, SUN1, and SUN2 within the nuclear envelope of *Tor1A^+/+^* and *Tor1A^−/−^* MEFs ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib68]; [@bib44]; [@bib35]). Of the five constructs tested, only EGFP--mini-N2G exhibited a difference in the absence of TA. Specifically, the *t*~1/2~ of EGFP--mini-N2G recovery after photobleaching was significantly increased in *Tor1A^−/−^* MEFs relative to controls ([Fig. 5 B](#fig5){ref-type="fig"}). Consequently, these results suggest that TA is required for the proper mobility of EGFP-N2G within the nuclear envelope.

![**TA affects the dynamics of EGFP--mini-N2G in the nuclear envelope.** (A) Representative confocal fluorescence images of *Tor1A^+/+^* and *Tor1A^−/−^* MEFs expressing the indicated construct and subjected to FRAP. White boxes indicate bleached regions of interest. Bar, 10 µm. (B) *t*~1/2~ of recovery quantification from the experiments described in A. *n* ≥ 3. Error bars show SEM. \*\*, P \< 0.01; ns, not significant. N3α/β, nesprin-3α/β.](JCB_201507113_Fig5){#fig5}

TA and LAP1 are required for the retrograde flow of dorsal perinuclear actin cables {#s08}
-----------------------------------------------------------------------------------

Because the reorganization of N2G and SUN2 into TAN lines requires the formation of dorsal perinuclear actin cables, which do not require either N2G or SUN2 ([@bib35]; [@bib11]), we tested the effect of TA depletion on the assembly of these cables in LPA-stimulated NIH3T3 fibroblasts. We did not detect a significant difference in the number of dorsal perinuclear actin cables in TA-depleted or control cells at 0, 60, or 120 min after LPA stimulation ([Fig. 6, A and B](#fig6){ref-type="fig"}). Although similar results were obtained in LAP1-depleted cells, they exhibited a significant reduction in cable numbers at the 0-min time point relative to control cells. Thus, neither TA nor LAP1 is required for the assembly of the actin cables responsible for rearward nuclear movement.

![**The retrograde flow of dorsal perinuclear actin cables during rearward nuclear movement requires TA and LAP1.** (A) Representative epifluorescence images of nuclei in NIH3T3 fibroblasts treated with the indicated siRNAs taken at 0, 60, and 120 min after LPA treatment. Bar, 10 µm. (B) Quantification of the number of dorsal perinuclear actin cables from the cells described in A. *n* ≥ 3. (C) Kymographs of retrograde actin cable flow in wound-edge NIH3T3 fibroblasts treated with the indicated siRNA and expressing Lifeact-mCherry. (D) Speed of actin cable retrograde flow quantified from the cells described in C. *n* ≥ 15. (E) Kymographs of retrograde actin flow in NIH3T3 fibroblasts expressing the indicated construct. Time after LPA addition is in mins. (C and E) Each panel is 0.2 µm. Time after LPA addition is in minutes. Dashed lines represent edges of the nucleus. Orange arrowheads indicate actin cables at the leading edge, and pink arrowheads indicate dorsal perinuclear actin cables. (F) Speed of actin cable retrograde flow determined from the cells described in E. *n* ≥ 10. Error bars are SEM. \*, P \< 0.05; ns, not significant.](JCB_201507113_Fig6){#fig6}

We then tested the ability of dorsal perinuclear actin cables in TA- or LAP1-depleted NIH3T3 fibroblasts to undergo retrograde flow by monitoring actin cables with the live-cell actin probe Lifeact-mCherry ([@bib47]). The speed of retrograde flow of the dorsal perinuclear actin cables was reduced by \>50% in TA- and LAP1-depleted cells relative to control cells, whereas retrograde flow of wound-edge actin cables was unaffected ([Fig. 6, C and D](#fig6){ref-type="fig"}). Because overexpression of SS-EGFP-TA^E171Q^ inhibited rearward nuclear positioning in NIH3T3 fibroblasts, we tested the effect of its expression on retrograde actin flow in these cells. Similar to what we observed in TA- or LAP1-depleted cells, the retrograde flow of dorsal perinuclear actin cables was inhibited by the overexpression of SS-EGFP-TA^E171Q^, whereas expression of SS-EGFP-TA^WT^ had no effect ([Fig. 6, E and F](#fig6){ref-type="fig"}). Therefore, TA and LAP1 are also required for the retrograde flow of dorsal perinuclear actin cables during centrosome orientation.

Discussion {#s09}
==========

We show that rearward nuclear movement during centrosome orientation requires TA and its activator, LAP1. Collectively, TA and LAP1 promote TAN line assembly and the retrograde flow of dorsal perinuclear actin cables, both of which are critical for rearward nuclear movement ([Fig. 7](#fig7){ref-type="fig"}). We also demonstrate that TA is necessary for the proper accumulation of EGFP--mini-N2G in TAN lines, perhaps because without TA, the mobility of EGFP--mini-N2G within the nuclear envelope is reduced. Thus, our results establish TA as a key regulator of LINC complex--dependent nuclear--cytoskeletal coupling and actin retrograde flow.

![**TA and LAP1 are critical regulators of rearward nuclear movement.** Model displaying the potential positions of TA and LAP1 within the two pathways known to contribute to proper centrosome orientation ([@bib14]; [@bib52]; [@bib35]). MRCK is sufficient to stimulate centrosome orientation and so may also regulate the centrosome centration pathway (dotted arrows; [@bib14]).](JCB_201507113_Fig7){#fig7}

Functional specification of torsin proteins {#s10}
-------------------------------------------

Although we cannot formally conclude that the other luminal torsins we tested are not required for centrosome orientation, our data suggest that TA plays a more significant role than TB, T2, or T3 during this process. This functional specificity for TA is unexpected, as TA and TB are known to function redundantly to maintain normal nuclear membrane morphology in nonneuronal cells ([@bib29]). In addition, TB, T2, and T3 all interact with LAP1 ([@bib24]; [@bib27]; [@bib29]). However, it is highly likely that different torsins perform specialized cellular functions as indicated by the fact that ATP hydrolysis--defective, substrate-trap TB, T2, and T3 mutants accumulate to varying degrees within the perinuclear space ([@bib24]; [@bib27]; [@bib29]). Moreover, the ATPase activity of these torsins is differentially stimulated by LAP1^LD^ or LULL1^LD^ in vitro ([@bib69]). The significant, rearward displacement of the centrosome that we observed in NIH3T3 fibroblasts after the overexpression of SS-EGFP--tagged TB^WT^, TB^E178Q^, T2^WT^, and T3^WT^ may also hint at functional specificity between torsin proteins. We hypothesize that TB, T2, or T3 may act to control MT dynamics, which are critical for proper centrosome positioning in migrating fibroblasts ([@bib14]; [@bib52]). Specifically, these torsins may regulate a growing list of known MT- or MT motor--associated membrane proteins that traverse the ER/ONM ([@bib21]).

TA-LAP1 holoenzyme-mediated rearward nuclear movement {#s11}
-----------------------------------------------------

We show that the redox-regulated ATPase activity of TA is required for rearward nuclear movement during centrosome orientation. We also demonstrate that mutations in TA (ΔE and RSS) that impair LAP1 or LULL1 binding ([@bib40]; [@bib74]; [@bib69]) are unable to rescue rearward nuclear movement in *Tor1A^−/−^* MEFs. The small amount of centrosome orientation we observed after expression of SS-EGFP-TA^E171Q^ in NIH3T3 fibroblasts versus the inability of this construct to rescue centrosome orientation in *Tor1A^−/−^* MEFs above background levels may be explained by the fact that AAA+ proteins typically act as ring-shaped hexamers ([@bib22]). Therefore, the presence of TA^WT^ in NIH3T3 fibroblasts could compensate for the ATP hydrolysis--defective E171Q mutation depending on the ratio of TA^WT^ to TA^E171Q^ in a single ring. However, expression of SS-EGFP-TA^E171Q^ in the *Tor1A^−/−^* would result in all TA rings being solely composed of ATP hydrolysis--defective TA and hence nonfunctional.

In addition, we provide evidence for the lack of functional redundancy between LAP1 and LULL1 during rearward nuclear movement despite the ability of both of their LDs to stimulate the ATPase activity of TA in vitro ([@bib69]). The requirement for LAP1 during rearward nuclear movement necessitated that its LD be tethered at the INM. Unexpectedly, we found that the critical arginine finger in the LAP1^LD^ (R442) was dispensable for LAP1 function during rearward nuclear movement. However, it is important to note that the effect of the arginine finger on the ability of the LAP1^LD^ to stimulate TA's ATPase activity in vitro varied greatly between two independent studies ([@bib3]; [@bib59]). Because these measurements were performed in the absence of a TA substrate, they may not accurately reflect TA activity in cells.

Our in vivo results concerning the critical nature of this conserved LAP1 arginine imply that LAP1 may perform other functions in addition to its ability to stimulate TA ATPase activity. It is possible that the stimulation of TA by the LAP1^LD^ is not important for rearward nuclear movement. Unidentified substrates and/or an additional activator within the perinuclear space may stimulate TA within this subcellular compartment, which would be consistent with the inability of either SS-EGFP-TA^E171Q^ or SS-EGFP-TA^K108A^ to rescue rearward nuclear positioning or centrosome orientation in *Tor1A^−/−^* MEFs. Another possible explanation for our results would be that EGFP-LAP1^R442A^ retains enough activity to stimulate ATP hydrolysis by TA in LAP1-depleted NIH3T3 fibroblasts. This would be in line with the modest effect of mutating the conserved arginine to alanine, as reported by [@bib59] in their in vitro experiments. Recently, a high-resolution crystal structure of TA in a complex with the LULL1^LD^ was solved, which will provide a critical structural framework for future experiments designed to further test the structure--function relationship between TA and LAP1 ([@bib10]).

TA and TAN line assembly {#s12}
------------------------

TA has been proposed to be a regulator of LINC complex assembly and function ([@bib12]; [@bib1]; [@bib51]). However, the mechanism underlying this proposed function remains unclear, aside from studies of an interaction between TA and the KASH domains from nesprins-1, -2, and -3 ([@bib41]) as well as the sensitivity of N2G, nesprin-3, and SUN2 nuclear envelope localization to the levels of TA ([@bib41]; [@bib64]). Although we detected a significant reduction in the nuclear envelope localization of SUN1 and N2G, we did not detect altered levels of nesprin-3 or SUN2 in the complete absence of TA. Furthermore, we were unable to detect any changes in either nuclear envelope localization or the levels of these proteins after TA or LAP1 depletion, with the exception of elevated nuclear envelope SUN2 levels after LAP1 depletion. Our inability to detect a significant reduction in the levels of N2G and SUN1 in TA-depleted NIH3T3 fibroblasts may result from an incomplete knockdown, consistent with TA being a very stable protein ([@bib13]). Because centrosome orientation and rearward nuclear movement were both inhibited in the *Tor1A^−/−^* MEFs as well as in TA- or LAP1-depleted NIH3T3 fibroblasts, we do not believe that the changes in N2G, SUN1, or SUN2 levels reflect a general function for TA in controlling the stability or localization of these proteins. Instead, we propose that TA regulates the mobility of N2G by acting as a molecular chaperone to structurally remodel N2G-containing protein complexes within the nuclear envelope.

This hypothesis is supported by our results demonstrating that TA and LAP1 are required for the assembly of stable TAN lines, which are linear arrays of LINC complexes composed of N2G and SUN2 ([@bib35], [@bib36]). In addition, the localization of TA to TAN lines further strengthens the connection between TA and N2G-containing protein complexes and raises the possibility that TA may act directly in the assembly of TAN lines. Although we did measure a significant enrichment of TA levels in TAN lines as compared with adjacent TAN line--free regions of the nuclear envelope, we did not see a preferential accumulation of TA^E171Q^ relative to TA^WT^ in TAN lines. Instead, we found a slight but significant decrease in the amount of TA^E171Q^ present in TAN lines as compared with TA^WT^. This result indicates that the ability of TA to localize to TAN lines may be somewhat sensitive to its nucleotide state and that TAN lines themselves may not be substrates for TA. Nevertheless, the presence of TA^E171Q^ in TAN lines did result in a significant reduction of the amount of mini-N2G in these structures relative to the mini-N2G levels measured in the presence of TA^WT^.

We offer the following potential explanation for the effect of TA^E171Q^ on mini-N2G levels in TAN lines. TA^E171Q^ may preferentially interact with and structurally remodel a previously unidentified TA substrate important for controlling the mobility of N2G within the nuclear envelope and hence the assembly of stable TAN lines. We predict that this substrate is either N2G itself, which would be consistent with the previous study of an interaction between TA and the KASH domains from nesprin-1, -2, and -3 ([@bib41]), or another N2G-interacting protein. Supporting evidence for this hypothesis is provided by our FRAP experiments, which revealed a significantly increased *t*~1/2~ of recovery for EGFP--mini-N2G in the absence of TA, suggesting that TA is needed for the proper assembly dynamics of N2G-containing LINC complexes required for TAN line assembly.

Previously, we showed that the KASH peptide is necessary and sufficient to immobilize EGFP--mini-N2G in the nuclear envelope of MEFs ([@bib44]). In addition, we demonstrated that SUN2 depletion significantly decreases the *t*~1/2~ of EGFP--mini-N2G recovery, whereas SUN1 depletion had no effect ([@bib44]). Although the total levels of N2G, SUN1, and SUN2 were significantly altered in the *Tor1A^−/−^* MEFs, we do not believe that these alterations are responsible for the increased *t*~1/2~ of EGFP--mini-N2G that we measured in these cells. For example, if reduced N2G levels were to create free binding sites within the perinuclear space for EGFP--mini-N2G, then this would apply to all nesprin proteins, given the promiscuous ability of KASH peptides to interact with SUN1 and SUN2 ([@bib61]). A similar argument could apply to the elevated SUN2 levels we observed in the *Tor1A^−/−^* MEFs, as this would also increase the number of potential nesprin-binding sites. Our inability to detect significant differences in EGFP--nesprin-3α/β mobility in the *Tor1A^−/−^* MEFs, which also interact with SUN1 and SUN2 ([@bib28]), strongly suggests that TA selectively regulates the mobility of N2G within the perinuclear space. Furthermore, the lack of change in EGFP-SUN1 or EGFP-SUN2 mobility demonstrates that the absence of TA does not influence the number of EGFP--mini-N2G--binding sites, despite elevated SUN2 and decreased SUN1 levels.

Based on these results, we postulate two potential direct mechanisms for how TA controls TAN line assembly. In the first, TA may promote the turnover of N2G-containing LINC complexes by dissociating the luminal N2G KASH peptide from SUN2. In the second, the previously studied TA--KASH domain interaction ([@bib41]) may preclude SUN protein binding, which would contribute to N2G mobility within the nuclear envelope. It is important to note that in order for either of these hypotheses to be feasible, TA would have to act from a position near the ONM. However, using our EGFP-tagged LAP1/LULL1 chimeric constructs, we show that the LAP1^LD^ needs to be anchored at the INM via the LAP1^ND-TMD^ to rescue rearward nuclear positioning and centrosome orientation in LAP1-depleted NIH3T3 fibroblasts. Because the distance between the ONM and INM is ∼30--50 nm ([@bib39]; [@bib9]; [@bib5]), this would necessitate TA being able to dissociate from the inner leaflet of the INM and then diffuse to the ONM, where it could access the N2G KASH domain and/or the SUN domain of SUN2. Interestingly, a small population of TA has been shown to be soluble within the ER lumen/perinuclear space in addition to a large membrane-associated population of TA using cellular fractionation ([@bib64], [@bib65]). Furthermore, TA was recently shown to undergo a proteolytic processing event during B cell activation, resulting in the cleavage of its hydrophobic N terminus, which mediates the monotopic association of TA with the inner leaflet of the ER/nuclear envelope membrane ([@bib70]). We hypothesize that in addition to stimulating the ATPase activity of TA, the interaction between TA and the LAP1^LD^ or the LULL1^LD^ may serve to regulate the membrane association of TA, thereby allowing it access to the ONM.

Alternatively, TA may indirectly influence TAN line assembly by its recently described role in regulating lipid metabolism ([@bib19]). For example, changes in the lipid composition of the nuclear envelope could potentially explain the reduced mobility of EGFP--mini-N2G that we observed in the *Tor1A*^−/−^ MEFs. However, such a global alteration in the biophysical nature of the nuclear envelope would most likely cause pleiotropic effects on the mobility of multiple nuclear envelope membrane proteins. Although we did not find alterations in the mobility of the five other nuclear envelope membrane proteins we measured here, it remains a formal possibility that TA regulates the metabolism of lipids that are specifically involved in N2G mobility. Clearly, future in vitro biochemical experiments are necessary to differentiate between these direct and indirect potential mechanisms of TA-mediated regulation of N2G.

TA is a novel regulator of dorsal perinuclear retrograde actin flow {#s13}
-------------------------------------------------------------------

Previously, TA had been implicated in the regulation of the actin cytoskeleton ([@bib25]; [@bib38]). Our finding that TA is required for the retrograde flow of dorsal perinuclear actin cables and not their assembly extends these results and offers two new insights: (1) TA controls the actin cytoskeleton from within the perinuclear space, and/or (2) retrograde actin flow at different subcellular locations is subject to differential regulation. To control retrograde actin flow from its luminal residence, TA must interact with and regulate a transmembrane ER or ONM protein involved in the regulation of the actin cytoskeleton. LAP1 is a strong candidate because our results show that it is also required for this process. Recently, LAP1^ND^ was reported to directly interact with the ND of emerin, which is primarily concentrated in the INM but also found at the ONM ([@bib49]; [@bib6]; [@bib56]). Emerin interacts with actin and nonmuscle myosin IIB within the cytoplasm and is also required for rearward nuclear movement during centrosome orientation in migrating fibroblasts ([@bib6]). Future efforts toward mapping the emerin-binding site or sites in LAP1^ND^ will enable the role of the LAP1--emerin interaction during centrosome orientation to be addressed. Alternatively, TA may control the actin cytoskeleton through a different LAP1-binding partner or a non-LAP1 nuclear membrane protein. Analysis of the recently published LAP1 interactome ([@bib55]), together with proteomics-based approaches to identify novel LAP1- and TA-interacting proteins, should help lead to the identification of potential TA substrates required for rearward nuclear movement during centrosome orientation.

TA-mediated cell polarity and DYT1 dystonia {#s14}
-------------------------------------------

In summary, our data support the hypothesis that TA plays a critical evolutionarily conserved role in the establishment and/or maintenance of cell polarity ([@bib2]; [@bib41]). When considered together with the recent study of fibroblasts derived from DYT1 dystonia patients being defective in centrosome orientation and directional migration ([@bib43]), our results highlight the possible connection between defective cell polarity and DYT1 dystonia. Although DYT1 dystonia is caused by neuronal dysfunction ([@bib32]), fibroblasts may provide an experimental model for investigating the molecular and cellular mechanisms underlying TA-dependent cell polarity. Ultimately, a better understanding of these mechanisms will guide the rational design of potential therapeutics that may be used to combat DYT1 dystonia pathogenesis.

Materials and methods {#s15}
=====================

Antibodies {#s16}
----------

β-Catenin mouse mAb and rabbit polyclonal antibody were purchased from Invitrogen. GAPDH mouse mAb was from Sigma-Aldrich. TA rabbit polyclonal antibody was from Abcam. EGFP mouse mAb and dsRed rabbit polyclonal antibody were purchased from Sigma-Aldrich and Takara Bio Inc., respectively. Lamin A/C (MANLAC1) mouse mAb was a gift from G.E. Morris (The Wolfson Centre for Inherited Neuromuscular Disease, Shropshire, England, UK). LAP1 and LULL1 rabbit polyclonal antibodies were previously described ([@bib16]). Pericentrin mouse mAb and rabbit polyclonal antibody were purchased from Covance or BD. The N2G rabbit polyclonal antibody was previously described ([@bib35]), as was the nesprin-3 rabbit polyclonal antibody ([@bib37]), which was a gift from D. Starr (University of California, Davis, Davis, CA). Tyrosinated α-tubulin rat mAb (YL1/2) was collected in house from a supernatant generated by hybridomas purchased from the European Collection of Animal Cell Cultures. SUN1 and SUN2 rabbit polyclonal antibodies were purchased from Abcam. Vinculin mouse mAb was from Sigma-Aldrich. Secondary antibodies were from three different sources. From Jackson ImmunoResearch Laboratories, Inc., we purchased goat anti--mouse secondary antibodies conjugated to Alexa Fluor 488 or 650 as well as rhodamine. We purchased goat anti--rat and anti--rabbit secondary antibodies conjugated to Dylight 488, 561, or 649 from Thermo Fischer Scientific. IRDye 650 nm--conjugated goat anti--mouse secondary antibodies were from LI-COR Biosciences.

Cell culture and monolayer wounding {#s17}
-----------------------------------

NIH3T3 fibroblasts were cultured in DMEM with 10% bovine calf serum purchased from Thermo Fischer Scientific. Fibroblasts were serum starved for 2 d, wounded, and stimulated with 10 µM LPA as previously described ([@bib46]; [@bib14]). MEFs were grown in DMEM with 15% bovine calf serum, serum starved for 3 d, wounded, and stimulated with 10 µM LPA.

DNA constructs {#s18}
--------------

The Lifeact-mCherry plasmid was a gift from R. Wedlich-Soldner (Max Planck Institute of Biochemistry, Martinsried, Germany; [@bib47]). The previously described EGFP-N3α and -N3β constructs ([@bib68]) were gifts from A. Sonnenberg (Netherlands Cancer Institute, Amsterdam, Netherlands). We have previously described the SS-EGFP-TA^WT^, -TA^K108A^, -TA^E171Q^, -TA^ΔE302/303^, -TB^WT^, -TB^E178Q^, -T2^WT^, -T2^E162Q^, -T3^WT^, -T3^E236Q^, and --mini-N2G constructs ([@bib15]; [@bib29]; [@bib35]).

The following constructs were generated during the course of this investigation using the primers described in Table S1. All constructs were confirmed by sequencing performed at the University of Minnesota Genomics Center. The following mutations were introduced into SS-EGFP-TA^WT^: C280S, C319S, and C280,319S using QuikChange (Agilent Technologies) following the manufacturer's instructions. SS-EGFP-TA^C280S^ was created using the TA^C280S^-forward and TA^C280S^-reverse primer pair, whereas the primer pair TA^C319S^-forward and TA^C319S^-reverse was used to create SS-EGFP-TA^C319S^. SS-EGFP-TA^C280,319S^ was generated using the TA^C319S^-forward and TA^C319S^-reverse primer pair to mutagenize SS-EGFP-TA^C280S^. To make the EGFP-LAP1^WT^ construct, we used PCR to amplify EGFP from pEGFP-N1 using the primers EGFP-LAP1^WT^-forward and EGFP-LAP1^WT^-reverse, both of which contain KpnI cut sites. The resulting PCR product was then purified and digested alongside the previously described myc-LAP1 construct ([@bib16]) with RE1 and RE2. The digested PCR product and plasmid were then purified and ligated to make EGFP-LAP1^WT^. EGFP-LAP1^R442A^ was created via kinase-ligase-DpnI treatment, where 2 µl of PCR product, amplified using the primer pair EGFP-LAP1^R442A^-forward and EGFP-LAP1^R442A^-reverse, was treated with T4 ligase, T4 polynucleotide kinase, and DpnI in T4 ligase buffer in a 20-µl reaction for 20 min at room temperature.

The chimeric EGFP-LAP1^ND-TMD^-LULL1^LD^ and EGFP-LULL1^CD-TMD^-LAP1^LD^ constructs were generated as follows. The first step toward creating EGFP-LAP1^ND-TMD^-LULL1^LD^ was to amplify the ND through the TMD of LAP1 by PCR, using the primer pair LAP1^ND-TMD^-forward and LAP1^ND-TMD^-reverse. After purification, the PCR product was used in combination with the LAP1^LD^-reverse primer to amplify the LULL1^LD^ by PCR from a previously described myc-LULL1 construct ([@bib16]). The resulting PCR product was then purified, digested with HindIII and BamHI, and cloned into pEGFP-C1, which was then digested with the same restriction enzymes. A similar protocol was followed to generate EGFP-LULL1^CD-TMD^-LAP1^LD^. However, the first PCR product was produced using the primer pair LULL1^CD-TMD^-forward and LULL1^CD-TMD^-reverse and myc-LULL1 as a template. The second PCR product was then generated using the first PCR product and LAP1^LD^-reverse as primers and myc-LAP1 as a template. After purification, the second PCR product was digested with HindIII and BamHI and cloned into pEGFP-C1, which was digested with the same restriction enzymes.

DNA microinjections {#s19}
-------------------

Plasmid DNA was purified using the Plasmid Midi kit (QIAGEN) and was microinjected into nuclei at concentrations between 5 and 30 µg/ml as previously described ([@bib14]). Injections were performed on a TS100 microscope (Nikon) equipped with a chrome-free infinity Apochromat long working distance apodized dark low 20×/NA 0.4 objective (3-mm working distance) and a Narishige NT-88 manipulator set (Nikon).

Fixed-cell fluorescence imaging {#s20}
-------------------------------

All fixed-cell imaging was performed on an Eclipse Ni-E microscope driven by NIS-Elements software using an oil immersion 40×/1.30 NA Plan Fluor Eco-Glass oil immersion objective lens (0.20-mm working distance; Nikon), a SOLA solid state white-light excitation subsystem (Lumencor), and a CoolSNAP ES2 12-bit 20-MHz digital monochrome charge-coupled device camera (Photometrics). A custom DAPI filter for the SOLA light source was used, which consisted of an ET 395/25× excitation filter and an ET 460/50-m emission filter purchased from Chroma Technology Corp. EGFP (C-FL EGFP hard coat high signal to noise Zero Shift), Texas Red (C-FL Texas Red hard coat high signal to noise Zero Shift), and Cy5 (C-FL CY5 hard coat high signal to noise Zero Shift; Nikon) filter sets were also used.

FRAP {#s21}
----

FRAP was performed with an LSM 510 META scanning confocal microscope equipped with a 30-mW argon 488-nm laser and a 40×/1.3 NA Plan-Apochromat objective (ZEISS) as previously described ([@bib44]). In brief, a region of interest was selected and photobleached for 25 iterations at 100% laser power, after which recovery of fluorescence was monitored with 2-s intervals at 5% laser power. ImageJ (National Institutes of Health) was then used to quantify the mean intensity of the fluorescence within the region of interest, which was normalized relative to the change in total fluorescence using the formula, *I*~rel~ = *T*~0~*I~t~/T~t~l*~0~, where *T*~0~ is the total cellular intensity during the prebleach, *T~t~* is the total cellular intensity at time point *t*, *I*~0~ is the mean intensity in the bleached area during prebleach, and *I~t~* is the mean intensity in the region of interest at time point *t*. The normalized fluorescence was then plotted against the time after bleaching.

Because the immobile fraction (the difference between the fluorescence intensity in the bleached area prebleach and the intensity at infinity after bleach) differed between the different EGFP-tagged constructs, we used a modified *t*~1/2~ value, where *t*~1/2~ is the time after bleach required for the fluorescence levels to reach the median between levels immediately after bleach and prebleach, rather than using the median between prebleach levels and steady-state levels. To determine *t*~1/2~, a modification of the method described by [@bib23] was used. We plotted ln(1 − *i~t~*) versus time after bleach, where *i~t~* is the mean normalized fluorescence intensity in the bleach region at time *t* and 1 is the mean normalized fluorescence intensity in the bleach region prebleach. The curves were fitted using KaleidaGraph (Synergy Software), and *t*~1/2~ was calculated as *t*~1/2~ = ln~2~ × (−1/slope). Data from the first 31 s after bleach were used in all experiments. The *t*~1/2~ of recovery was calculated from at least three independent experiments.

Immunofluorescence {#s22}
------------------

Cells grown on no. 1.5 coverslips were fixed in either −20°C methanol or room temperature 4% paraformaldehyde as previously described ([@bib46]; [@bib14]). Coverslips were mounted on slides using Fluoromount purchased from Thermo Fisher Scientific.

Live-cell DIC and fluorescence imaging {#s23}
--------------------------------------

NIH3T3 fibroblasts or MEFs were grown on 35-mm dishes with glass coverslip bottoms (0.16--0.19 mm; no. 1.5) purchased from In Vitro Scientific. Confluent monolayers were serum starved and wounded as described in the Cell culture and monolayer wounding section. Cells were then washed twice with live imaging media (GIBCO HBSS \[purchased from Invitrogen\] containing essential and nonessential MEM amino acids purchased from Thermo Fisher Scientific), 2.5 g/liter glucose, 2 mM glutamine, 1 mM sodium pyruvate, and 20 mM Hepes, pH 7.4) and transferred to the 37°C full-enclosure incubator (Okolab USA Inc.) with temperature control attached to a Marianas 200 Microscopy Workstation (Intelligent Imaging Innovations) built on an AxioObserver Z.1 stand (ZEISS) and driven by SlideBook 6.0 software (Intelligent Imaging Innovations). After selecting the regions of the coverslip to be imaged, the cells were stimulated with 20 µM LPA. DIC images were captured with a CoolSNAP HQ2 charge-coupled device camera. Fluorescence confocal imaging was performed with a 5,000-rpm CSU-X1 M1 spinning-disk confocal head (Yokogawa Electric Corporation) and an Evolve electron-multiplying charge-coupled device camera (Photometrics). A LaserStack laser launch containing two 50-mW solid-state lasers (488 nm and 561 nm; Intelligent Imaging Innovations) was used as a light source for the live-cell fluorescence imaging. A CSUX filter wheel (Yokogawa Electric Corporation) containing Semrock filters for 405-, 488-, 561-, or 640-nm excitation and with a quad emitter and individual emitters was used as the filter set. All live-cell imaging was performed using a Plan-Apochromat 63×/1.4 NA oil objective (ZEISS) containing DIC III prisms.

Quantification of dorsal perinuclear actin cables {#s24}
-------------------------------------------------

LPA- and serum-stimulated wound-edge NIH3T3 fibroblasts that had been stained for F-actin and nuclei were used to assess the effect of siRNA-mediated TA and LAP1 depletion on dorsal perinuclear actin cables. Dorsal actin cables above the nucleus were manually counted from single-plane images taken of F-actin and nuclei, counting only those actin cables that passed over the nucleus.

Quantification of nuclear envelope protein levels {#s25}
-------------------------------------------------

11 z-section epifluorescence images of LPA-stimulated wound-edge fibroblasts stained for DNA, MTs, and a nuclear envelope protein were obtained with a 300-nm step size. After acquiring the images, the "select best planes" function from NIS-Elements software was used to select a single z section from each imaged area of cells, using the MT channel as the guide for selecting the in-focus section. The selected images were then exported as 16-bit greyscale TIFF files and imported into custom-made MATLAB software (MathWorks) for analysis. This software applies a mask to the DAPI-stained DNA channel using the "canny edge detection" algorithm. The user then identifies the nuclei on the wound edge to be analyzed, and the program integrates the intensity of the nuclear envelope protein channel within the DAPI mask and then divides that intensity by the area of the mask.

Quantification of rearward nuclear movement {#s26}
-------------------------------------------

Multipage TIFF files were obtained for each cell imaged using DIC microscopy, with a single z section (or maximum intensity projection) and time along the third axis of each image. TIFF files were then imported into custom MATLAB software for quantifying nuclear movement. Using this software, the user defined the wound edge and then manually traced an outline of the nucleus in the cell of interest at each time step. Next, the "region props" function was used, which calculates the centroid, area, eccentricity, and absolute angle of the major axis of the traced object. Using Excel (Microsoft), the coordinates of our wound clicks were then rotated so that each cell analyzed was parallel to the x axis, providing a similar point of reference for each nucleus. Once rotated, the changes in nuclear centroid position over time were used to determine overall speed (displacement) during the 2-h time course. Nuclei that moved ≥10% of the cell radius toward the cell rear were defined as rearward-moving nuclei. Experiments were repeated at least twice.

Quantification of nucleus and centrosome position {#s27}
-------------------------------------------------

Fluorescence images of cells stained for centrosomes (antipericentrin), cell--cell contacts (anti--β-catenin), DNA (DAPI), expression tag, and MTs (anti-Tyr--α-tubulin) were acquired as previously described ([@bib46]; [@bib14]). Centrosome orientation was determined as previously described ([@bib46]), and experiments were repeated up to three times. Analysis of the nucleus and centrosome position was performed as previously described ([@bib14]). In brief, images were pseudocolored, combined, and aligned so that the wound edge was parallel to the x axis using MetaMorph software (Molecular Devices). Cell perimeters were drawn over the cell--cell contacts (β-catenin) and the wound edge (Tyr-tubulin or injection markers). From this information, the cell centroid and equivalent radius were calculated using the "integrated morphometry analysis" program in MetaMorph. The MetaMorph "measure pixel" function was used to identify the position of the centrosome (pericentrin) and the approximate centroid of the nucleus. A vector representing the distances from the nuclear centroid and the centrosome to the cell centroid was drawn and resolved into x and y coordinates (parallel and perpendicular to the leading edge, respectively). Measurements were normalized to cell size to allow for a comparison between cells. Only the y coordinate was used in plots, as the x coordinate (position of the nuclear centroid or centrosome along the x axis) did not change significantly. The difference between the cell centroid and the nucleus centroid or centrosome was then divided by the radius to determine the percentage of the cell radius either organelle traveled.

Quantification of retrograde actin flow {#s28}
---------------------------------------

Serum-starved wound-edge NIH3T3 fibroblasts treated with either NC or TA-targeting siRNAs were microinjected with the Lifeact-mCherry construct (20 ng/µl) and incubated for 1.5--2.0 h at 37°C to allow for expression. Cells were then washed with recording media and moved to the heated stage of our Marianas 200 Microscopy Workstation (described in the Live-cell DIC and fluorescence imaging section). Both Lifeact-mCherry expression and nuclear position (DIC) were imaged every 5 min for 2.0 h shortly after the addition of 20 µM LPA to allow tracking of both nuclear movement and F-actin. The resulting images were then rotated so that each wound edge was parallel to the x axis to keep the point of reference similar between cells. Nuclear tracking using the DIC channel was completed as described in the Quantification of rearward nuclear movement section. To track F-actin over the nucleus, we isolated a single plane on the dorsal side of the nucleus and tracked the y position of the center of individual actin cables between 35 and 90 min after LPA stimulation. To track F-actin in the cytoplasm, we created maximum-intensity projections of the cells and identified a region of the cell that was ∼2 µm directly rearward from the center of the wound edge, where we tracked individual cables between 35 and 90 min after LPA stimulation. Experiments were repeated three times.

Quantification of TAN line localization {#s29}
---------------------------------------

After acquisition as described in the Fixed-cell fluorescence imaging section, epifluorescence images were opened in ImageJ FIJI. A maximum-intensity projection of the image planes containing the top half of the nuclear envelope for each channel was created. Using mCherry--mini-N2G lines as a guide, the image was rotated without interpolation so that the TAN line was parallel to the x axis. The rotation was then propagated to the TA channel. An 11-pixel-tall box was then drawn to cover the length of the TAN line, with the central pixel centered on the TAN line. The mean intensity for each row of pixels was then calculated for each channel, and then each mean intensity was expressed as a percentage of the sum intensity of the whole measured region. The regions were then mirrored by taking the means of the 1st and the 11th, the 2nd and 10th, etc., pixel. This process was repeated for all TAN lines. Fractional fluorescence of each pixel row was then calculated, and the mean and SEM were plotted as a function of the distance from the center of the TAN lines. *n* ≥ 35 cells for each construct.

Quantification of TAN line persistence {#s30}
--------------------------------------

Serum-starved wound-edge NIH3T3 fibroblasts treated with either NC or TA-targeting siRNAs were microinjected with the EGFP--mini-N2G construct (5.5 ng/µl) and incubated for 45 min at 37°C to allow for expression. Cells were then washed with live-imaging media and moved to the heated stage of our Marianas 200 Microscopy Workstation (described in the Live-cell DIC and fluorescence imaging section). 19 z-section confocal stacks with a 0.4-µm step size of expressing cells were collected every 5 min for 2 h using a 63×/1.4 NA Plan-Apochromat DIC objective after stimulation with 20 µM LPA. After the acquisition time course was completed, videos were inspected in the 3D time-lapse view within SlideBook 6.0 to monitor the EGFP--mini-N2G signal on the dorsal nuclear surface. A maximum-intensity projection of the dorsal half of the nucleus was then generated using SlideBook 6.0 for the time course, in which TAN line persistence was analyzed by tracking individual TAN lines (linear EGFP--mini-N2G signals ≥2 µm in length) over time using ImageJ. Experiments were repeated three times.

Quantification of total protein levels by Western blotting {#s31}
----------------------------------------------------------

Whole-cell lysate samples were prepared by lysing cells with nonreducing sample buffer. Protein concentration was determined, and 15 µg protein was loaded onto protein gels (Novex; Thermo Fisher Scientific). Samples were subjected to SDS-PAGE and then transferred to nitrocellulose and probed with the indicated antibodies. Blots were imaged, and bands were quantified using the Odyssey Imaging System and Image Studio software (LI-COR Biosciences). All experiments were repeated three times.

Reagents {#s32}
--------

F-actin was stained with rhodamine-phalloidin, which was purchased from Cytoskeleton, Inc. DAPI was purchased from Thermo Fisher Scientific. LPA was purchased from Avanti Polar Lipids, Inc. Restriction enzymes were purchased from either New England Biolabs, Inc. or Promega. The QuikChange kit was purchased from Agilent Technologies. Phusion DNA polymerase, T4 DNA ligase, and T4 polynucleotide kinase were also purchased from New England Biolabs, Inc. All other chemicals were from Sigma-Aldrich unless otherwise specified. The Wizard SV Gel and PCR Clean-Up system was from Promega. The GeneJet Plasmid Midiprep kit was from Thermo Fisher Scientific.

RNAi {#s33}
----

All RNAi experiments were performed using 50-nM siRNA duplexes purchased from Shanghai GenePharma, which were transfected using Lipofectamine RNAiMAX purchased from Thermo Fisher Scientific according to the manufacturer's instructions. To identify functional siRNA duplexes, four sequences were selected using the artificial neural network algorithm BIOPREDsi ([@bib26]). The duplexes used in this study were the most effective at depleting the target protein based on Western blotting or RT-PCR analysis. The sequences of the duplexes used are described in Table S2. The GAPDH and N2G siRNA sequences were previously described ([@bib35]).

Statistics {#s34}
----------

Two-tailed *t* tests were used to calculate p-values (\*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001) throughout the manuscript. The error bars presented in bar graphs throughout the manuscript show SEM.

Online supplemental material {#s35}
----------------------------

Fig. S1 shows the validation of torsin protein depletion from NIH3T3 fibroblasts by various siRNAs. Fig. S2 shows the testing of the roles of TB, T2, and T3 during rearward nuclear positioning and centrosome orientation in NIH3T3 fibroblasts. Fig. S3 shows the validation of LAP1 and LULL1 depletion from NIH3T3 fibroblasts by various siRNAs. Fig. S4 shows quantification of the nuclear and biochemical levels of TAN line components in TA- and LAP1-depleted NIH3T3 fibroblasts as well as T1A^−/−^ MEFs. Fig. S5 shows quantification of endogenous SUN2 recruitment to TAN lines in NIH3T3 fibroblasts with impaired TA function. Table S1 shows the primers used to generate constructs used in this paper. Table S2 shows the sequences of siRNA duplexes used in this paper.
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